Adenovirally mediated gene transfer of functional human tissue-type plasminogen activator to Murine lungs

American Journal of Respiratory Cell and Molecular Biology

Volumn 18, Issue 3, 1998, Pages 307-314

  Simmons, Warren L ^a   Rivera, Kimberly E ^a   Curiel, David T ^a   Williams, Willie F ^a   Olman, Mitchell A ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRIDAE; CYTOMEGALOVIRUS; MURINAE;

TISSUE PLASMINOGEN ACTIVATOR;

ADENOVIRUS; ANIMAL; ARTICLE; BIOSYNTHESIS; C57BL MOUSE; CYTOMEGALOVIRUS; FEMALE; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; LUNG; METABOLISM; MOUSE; TISSUE DISTRIBUTION;

ADENOVIRIDAE; ANIMALS; CYTOMEGALOVIRUS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG; MICE; MICE, INBRED C57BL; TISSUE DISTRIBUTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0032014655     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/ajrcmb.18.3.2892     Document Type: Article

References (30)

1. Vassalli, J., A. Sappino, and D. Belin. 1991. The plasminogen activator/plasmin system. J. Clin. Invest. 88:1067-1072.
2. Olman, M. A., J. J. Marsh, I. M. Lang, K. M. Moser, B. R. Binder, and R. R. Schleef. 1992. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 86:1241-1248.
3. Olman, M., N. Mackman, C. Gladson, K. Moser, and D. Loskutoff. 1995. Changes in procoagulant and fibrinolytic gene expression during bleomycin induced lung injury in the mouse. J. Clin. Invest. 96:1621-1630.
4. Marshall, B. C., D. S. Sageser, N. V. Rao, M. Emi, and J. R. Hoidal. 1990. Alveolar epithelial cell plasminogen activator: characterization and regulation. J. Biol. Chem. 265:8198-8204.
5. Idell, S., K. K. James, E. G. Levin, B. S. Schwartz, N. Manchanda, R. J. Maunder, T. R. Martin, J. McLarty, and D. S. Fair. 1989. Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J. Clin. Invest. 84: 695-705.
6. Sitrin, R. G., P. G. Brubaker, and J. C. Fantone. 1987. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities. Am. Rev. Respir. Dis. 135: 930-938.
7. Bertozzi, P., B. Astedt, L. Zenzius, K. Lynch, F. LeMaire, W. Zapol, and H. A. Chapman. 1990. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N. Engl. J. Med. 322:890-897.
8. de Vries, C., H. Veerman, E. Koornneef, and H. Pannekoek. 1990. Tissue-type plasminogen activator and its substrate Glu-plasminogen share common binding sites in limited plasmin-digested fibrin. J. Biol. Chem. 265: 13547-13552.
9. Plow, E. F., T. Herren, A. Redlitz, L. A. Miles, and J. L. Hoover-Plow. 1995. The cell biology of the plasminogen system. FASEB J. 9:939-945.
10. Hajjar, K. A., A. T. Jacovina, and J. Chacko. 1994. An endothelial cell receptor for plasminogen/tissue plasminogen activator: I. Identity with annexin II. J. Biol. Chem. 269:21191-21197.
11. Crystal, R. G. 1995. Transfer of genes to humans: early lessons and obstacles to success. Science 270:404-410.
12. Kozarsky, K. F., and J. M. Wilson. 1993. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3:499-503.
13. Curiel, D. T., J. M. Pilewski, and S. M. Albelda. 1996. Gene therapy approaches for inherited and acquired lung diseases. Am. J. Respir. Cell Mol. Biol. 14:1-18.
14. Kolls, J., K. Peppel, M. Silva, and B. Beutler. 1994. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc. Natl. Acad. Sci. USA 91:215-219.
15. McCoy, R., B. Davidson, B. Roessler, G. Huffnagle, and R. Simon. 1995. Expression of human interleukin-1 receptor antagonist in mouse lungs using a recombinant adenovirus: effects on vector-induced inflammation. Gene Therapy 7:437-442.
16. Engelhardt, J. E., X. Ye, B. Doranz, and J. M. Wilson. 1994. Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases immune response in mouse liver. Proc. Acad. Acad. Sci. USA 91: 6196-6200.
17. Yang, Y., F. A. Nunes, K. Berensci, E. E. Furth, E. Gonczol, and J. M. Wilson. 1994. Cellular immunity to viral antigens limits El-deleted adenovirus for gene therapy. Proc. Natl. Acad. Sci. USA 91:4407-4411.
18. Ginsberg, H. S., L. L. Moldawer, P. B. Sehgal, M. Redington, P. L. Kilian, R. M. Chanock, and G. A. Prince. 1991. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc. Natl. Acad. Sci. USA 88:1651-1655.
19. Ghosh-Choudhury, G., Y. Haj-Ahmad, P. Brinkley, J. Rudy, and F. L. Graham. 1986. Human adenovirus cloning vectors based on infectious bacterial plasmids. Gene 50:161-171.
20. McGrory, W. J., D. S. Bautista, and F. L. Graham. 1988. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614-617.
21. Graham, F. L., and L. Prevec. 1991. Manipulation of adenovirus vectors. In Methods in Molecular Biology. E. J. Murray, editor. Humana Press, Clifton, NJ. 109-128.
22. Harris, C. E., S. Agarwal, P.-C. Hu, E. Wagner, and D. T. Curiel. 1993. Receptor-mediated gene transfer to airway epithelial cells in primary culture. Am. J. Respir. Cell Mol. Biol. 9:441-447.
23. Tang, D., S. A. Johnston, and D. P. Carbone. 1994. Butyrate-inducible and tumor-restricted gene expression by adenovirus vectors. Cancer Gene Therapy 1:15-20.
24. Olman, M. A., W. L. Simmons, D. J. Pollman, A. Y. Loftis, A. Bini, E. J. Miller, G. M. Fuller, and K. Rivera. 1996. Polymerization of tibrinogen in murine bleomycin-induced lung injury. Am. J. Physiol. 271:L519-L526.
25. Lang, I. M., J. J. Marsh, M. A. Olman, K. M. Moser, and R. R. Schleef. 1994. Parallel analysis of tissue-type plasminogen activator and type 1 plasminogen activator inhibitor in plasma and endothelial cells derived from patients with chronic pulmonary thromboemboli. Circulation 90:706-712.
26. Vassalli, J. D., and D. Belin. 1987. Amiloride selectively inhibits the urokinase-like plasminogen activator. FEBS Lett. 214:187-191.
27. Zar, J. U. 1984. Biostatistical Analysis. Prentice-Hall, Englewood Cliffs, NJ.
28. Kielberg, V., P. A. Andreasen, J. Grondahl-Hansen, L. S. Nielsen, L. Skriver, and K. Dano. 1985. Proenzyme to urokinase-type plasminogen activator in the mouse in vivo. FEBS Lett. 182:441-445.
29. Ekhterae, D., and J. C. Stanley. 1995. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells. J. Vasc. Surg. 21:953-962.
30. Lemarchand, P., M. Jones, C. Danel, I. Yamada, A. Mastrangeli, and R. G. Crystal. 1994. In vivo adenovirus-mediated gene transfer to lungs via pulmonary artery. J. Appl. Physiol. 76:2840-2845.